Location: Hebei
Synced from ClinicalTrials.gov · August 09, 2026
Clinical studies recruiting near Hebei
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile. Phase 1 · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Bre Phase 2 · Hebei Medical University Fourth Hospital · NCT04159142 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) Phase 3 · Bristol-Myers Squibb · NCT06929273 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod Phase 3 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis Phase 1/Phase 2 · Chipscreen Biosciences, Ltd. · NCT07129382 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease Phase 2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer Phase 1/Phase 2 · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Phase 2 · Kunming Pharmaceuticals, Inc. · NCT07279493 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi Phase 1 · Shanghai Henlius Biotech · NCT07160335 The Chinese Familial Alzheimer's Network Phase N/A · Capital Medical University · NCT03657732 Mobile Applet for Weight Management in Obese Heart Failure Patients NA · Heart Health Research Center · NCT06455878 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Amgen · NCT07037433 A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia Phase 3 · Hasten Biopharmaceutical Co., Ltd. · NCT06568471 Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer(Neo-Color) Phase 2 · Hebei Medical University Fourth Hospital · NCT06949111 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa Phase N/A · Bristol-Myers Squibb · NCT07361289 Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of Insulin Aspart Injections After Single- NA · Zhuhai United Laboratories Co., Ltd. · NCT07600944 Robot-Assisted vs Manual Transradial Cerebral Angiography NA · The First Hospital of Hebei Medical University · NCT07696936 Clinical Trials of Quadrivalent Influenza Vaccine Phase 1/Phase 2 · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie Phase 3 · Pfizer · NCT05895786 A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT06000956 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl Phase 2 · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297 Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens Phase N/A · Huashan Hospital · NCT07694648 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone Phase 3 · Celgene · NCT05519085 A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. Phase 1/Phase 2 · Jiangsu HengRui Medicine Co., Ltd. · NCT06015048 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1 Phase 1/Phase 2 · Allist Pharmaceuticals, Inc. · NCT05276726 Chinese Psoriasis Real World Evidence Research Phase N/A · the First Hospital of Hebei Medical University · Second Affiliated Hospital, Zhejiang University, School of M · NCT04465838 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis Phase N/A · AstraZeneca · NCT06465810 Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusio NA · Beijing Tiantan Hospital · NCT07323368 China HeadAche DIsorders RegiStry Phase N/A · Beijing Tiantan Hospital · NCT05334927
Look up another city
Look up another condition